Gastroesophageal reflux disease in primary care: Using changes in proton pump inhibitor therapy as an indicator of partial response

References

• Kahrilas PJ, Shaheen NJ, Vaezi MF, Hiltz SW, Black E, Modlin IM, American gastroenterological association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology 2008;135:1383–91.
   PubMed Web of Science ®Google Scholar
• van Pinxteren B, Numans ME, Bonis PA, Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev 2004;4:CD002095.
   Google Scholar
• Donnellan C, Sharma N, Preston C, Moayyedi P. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005;2:CD003245.
   Google Scholar
• El-Serag H, Becher A, Jones R. Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther 2010;32:720–37.
   PubMed Web of Science ®Google Scholar
• Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease – where next? Aliment Pharmacol Ther 2005;22:79–94.
   PubMed Web of Science ®Google Scholar
• Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastro-esophageal reflux disease (GERD) – a global evidence-based consensus. Am J Gastroenterol 2006;101:1900–20.
   PubMed Web of Science ®Google Scholar
• Diculescu M, Iacob R, Chira C, Mihaila D, Iacob S. Esomeprazole in the treatment of patients with heartburn and other upper gastrointestinal symptoms, referred to primary care – results of the in-practice evaluation program in Romania. Rom J Gastroenterol 2005;14:9–14.
   Google Scholar
• Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009;58:295–309.
   PubMed Web of Science ®Google Scholar
• Boeckxstaens GE, Denison H, Jensen JM, Lehmann A, Ruth M. Translational gastrointestinal pharmacology in the 21st century: 'the lesogaberan story'. Curr Opin Pharmacol 2011;11:630–3.
   PubMed Web of Science ®Google Scholar
• Boeckxstaens GE, Smout A. Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastroesophageal reflux disease. Aliment Pharmacol Ther 2010;32:334–43.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007;16:393–401.
   PubMed Web of Science ®Google Scholar
• Stuart-Buttle CD, Read JD, Sanderson HF, Sutton YM. A language of health in action: Read Codes, classifications and groupings. A conference of the American Medical Informatics Association. AMIA Annual Fall Symposium 1996;75–9.
   Google Scholar
• MULTILEX for primary care. 2010. Available from http://www.firstdatabank.co.uk/uploads/files/MultilexDDF%20for%20Primary%20Care.pdf. Accessed 25 January 2010.
   Google Scholar
• García Rodríguez LA, Ruigómez A, Martín-Merino E, Johansson S, Wallander M-A. Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest 2008;134:1223–30.
   PubMed Web of Science ®Google Scholar
• Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S, Dent J. Comparison of gastroesophageal reflux disease and heartburn diagnoses in UK primary care. Curr Med Res Opin 2006;22:1661–8.
   PubMed Web of Science ®Google Scholar
• Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S, Graffner H, Dent J. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004;20:751–60.
   PubMed Web of Science ®Google Scholar
• Ruigómez A, García Rodríguez LA, Wallander MA, Johansson S, Thomas M, Price D. Gastroesophageal reflux disease and asthma: a longitudinal study in UK general practice. Chest 2005;128:85–93.
   PubMed Web of Science ®Google Scholar
• Ruigómez A, Hungin AP, Lundborg P, Johansson S, Wallander MA, García Rodríguez LA. Treatment patterns in paediatric patients with a new diagnosis of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2011;23:232–7.
   Google Scholar
• Ruigómez A, Lundborg P, Johansson S, Wallander MA, García Rodríguez LA. Follow-up of a cohort of children and adolescents with gastro-esophageal reflux disease who were free of reflux esophagitis at initial diagnosis. Scand J Gastroenterol 2010;45:814–21.
   PubMed Web of Science ®Google Scholar
• Ruigómez A, Wallander M-A, Lundborg P, Johansson S, García Rodríguez LA. Gastroesophageal reflux disease in children and adolescents in primary care. Scand J Gastroenterol 2010;45:139–46.
   PubMed Web of Science ®Google Scholar
• El-Serag H, Hill C, Jones R. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care – a review of studies using the UK General Practice Research Database. Aliment Pharmacol Ther 2009;29:470–80.
   Google Scholar
• Gerson LB, Bonafede M, Princic N, Gregory C, Farr A, Balu S. Development of a refractory gastro-oesophageal reflux score using an administrative claims database. Aliment Pharmacol Ther 2011;34:555–67.
   PubMed Web of Science ®Google Scholar
• Kennedy T, Jones R. The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms. Aliment Pharmacol Ther 2000;14:1589–94.
   PubMed Web of Science ®Google Scholar
• Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? an evidence-based approach. Arch Intern Med 2006;166:965–71.
   PubMed Web of Science ®Google Scholar
• El-Serag H. Role of obesity in GORD-related disorders. Gut 2008;57:281–4.
   PubMed Web of Science ®Google Scholar
• Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199–211.
   PubMed Web of Science ®Google Scholar
• Zerbib F, Belhocine K, Simon M, Capdepont M, Mion F, Bruley des Varannes S, Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut 2011;61:501–6.
   Google Scholar
• Jansson C, Nordenstedt H, Wallander MA, Johansson S, Johnsen R, Hveem K, Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based study. Aliment Pharmacol Ther 2007;26:683–91.
   PubMed Web of Science ®Google Scholar
• Martin-Merino E, Ruigomez A, Garcia Rodriguez LA, Wallander MA, Johansson S. Depression and treatment with antidepressants are associated with the development of gastroesophageal reflux disease. Aliment Pharmacol Ther 2010;31:1132–40.
   PubMed Web of Science ®Google Scholar
• Martín-Merino E, Ruigómez A, Johansson S, Wallander M-A, García-Rodríguez LA. Study of a cohort of patients newly diagnosed with depression in general practice: prevalence, incidence, comorbidity and treatment patterns. Prim Care Companion J Clin Psychiatry 2010;12:e1–8.
   Google Scholar
• Wiklund I, Carlsson R, Carlsson J, Glise H. Psychological factors as a predictor of treatment response in patients with heartburn: A pooled analysis of clinical trials. Scand J Gastroenterol 2006;41:288–93.
   PubMed Web of Science ®Google Scholar
• Heading RC, Monnikes H, Tholen A, Schmitt H. Prediction of response to PPI therapy and factors influencing treatment outcome in patients with GORD: a prospective pragmatic trial using pantoprazole. BMC Gastroenterol 2011;11:52.
   PubMedGoogle Scholar
• Vakil N, Niklasson A, Denison H, Ryden A. Partial responders to a proton pump inhibitor in gastroesophageal reflux disease: symptom profile and prevalence of irritable bowel syndrome, anxiety and depression. Gut 2011;60(Suppl 3):A266– abstract P0781.
   Google Scholar
• Becher A, El-Serag H. Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011;34:618–27.
   PubMed Web of Science ®Google Scholar
• Hungin AP, Hill C, Molloy-Bland M, Raghunath A. Systematic review: patterns of proton pump inhibitor use and adherence in gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2012;10:109–16.
   PubMed Web of Science ®Google Scholar
• Bytzer P, Mattsson H, Wernersson B. Partial symptom response to proton pump inhibitors in patients with non-erosive reflux disease and reflux esophagitis. Gastroenterology 2011;140(5 Suppl 1):S-583.
   Google Scholar